| Sofuoglu, Mehmet |
| Completed | 1 | 16 | US | Nicotine, intravenous nicotine | Yale University, National Institute on Drug Abuse (NIDA) | Nicotine Dependence | 06/23 | 06/23 | | |
| Completed | 1 | 11 | US | 0.05, 0.025, and 0.0125 mg nicotine/pulse of nicotine, Saline | Yale University | Nicotine Dependence | 07/23 | 08/23 | | |
NCT05176418: IV Pulsed-Nicotine As a Model of Smoking: the Effects of Dose and Delivery Rate |
|
|
| Recruiting | 1 | 70 | US | low dose Nicotine, IV nicotine 1mg/70kg, high dose Nicotine, IV Nicotine 0.2/70kg | Yale University | Nicotine Dependence | 08/25 | 09/25 | | |
| Recruiting | 1 | 36 | US | Nicotine, Saline | Yale University, National Institute on Drug Abuse (NIDA) | Smoking Addiction | 01/27 | 01/27 | | |
| Aquino, Joao De |
| Recruiting | 2 | 147 | US | CBD 300mg, Nantheia™ ATL5 (300mg), CBD 600mg, Nantheia™ ATL5 (600mg), Placebo 0mg, Nantheia™ ATL5 (0mg) | Yale University, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH) | Chronic Pain, Opioid Use Disorder | 01/28 | 01/28 | | |
NCT05076370: Safety and Tolerability of Cannabidiol Among Persons With Opioid Use Disorder Receiving Methadone or Buprenorphine |
|
|
| Completed | 1 | 7 | US | CBD Day 1, CBD Day 2, CBD Day 3 | Yale University, National Institute on Drug Abuse (NIDA) | Addiction | 06/24 | 06/24 | | |
NCT04587791: Cannabidiol in Opioid Use Disorder and Chronic Pain |
|
|
| Recruiting | 1 | 40 | US | 400mg Cannabidiol, CBD, 800mg Cannabidiol, 1200mg Cannabidiol, Saline, placebo | Yale University, VA Connecticut Healthcare System, National Institute on Drug Abuse (NIDA) | Chronic Pain | 02/25 | 03/25 | | |
NCT04025359: Effects of Dronabinol in Opioid Maintained Patients |
|
|
| Recruiting | 1 | 36 | US | Dronabinol, Marinol, Placebo | Yale University, US Department of Veterans Affairs | Pain | 02/25 | 06/25 | | |
NCT05906511: PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults |
|
|
| Recruiting | 1 | 20 | US | Dronabinol 5 MG, "Marinol", Dronabinol 10 MG, 2mg Purified THC in an ethanolic solution, 4mg Purified THC in an ethanolic solution, Placebo | Yale University, VA Connecticut Healthcare System, National Institute on Drug Abuse (NIDA) | Pain, Tolerance, Oral vs Vaporized THC, Abuse Liability | 08/25 | 08/25 | | |
| Sullivan, Brendan |
| Completed | 1 | 11 | US | 0.05, 0.025, and 0.0125 mg nicotine/pulse of nicotine, Saline | Yale University | Nicotine Dependence | 07/23 | 08/23 | | |
NCT05076370: Safety and Tolerability of Cannabidiol Among Persons With Opioid Use Disorder Receiving Methadone or Buprenorphine |
|
|
| Completed | 1 | 7 | US | CBD Day 1, CBD Day 2, CBD Day 3 | Yale University, National Institute on Drug Abuse (NIDA) | Addiction | 06/24 | 06/24 | | |
NCT04025359: Effects of Dronabinol in Opioid Maintained Patients |
|
|
| Recruiting | 1 | 36 | US | Dronabinol, Marinol, Placebo | Yale University, US Department of Veterans Affairs | Pain | 02/25 | 06/25 | | |
NCT05906511: PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults |
|
|
| Recruiting | 1 | 20 | US | Dronabinol 5 MG, "Marinol", Dronabinol 10 MG, 2mg Purified THC in an ethanolic solution, 4mg Purified THC in an ethanolic solution, Placebo | Yale University, VA Connecticut Healthcare System, National Institute on Drug Abuse (NIDA) | Pain, Tolerance, Oral vs Vaporized THC, Abuse Liability | 08/25 | 08/25 | | |
| Recruiting | 1 | 36 | US | Nicotine, Saline | Yale University, National Institute on Drug Abuse (NIDA) | Smoking Addiction | 01/27 | 01/27 | | |
| MacLean, Robert R |
ACT-SS, NCT04567680: Acceptance and Commitment Therapy to Improve Social Support for Veterans With PTSD |
|
|
| Active, not recruiting | N/A | 120 | US | Acceptance and Commitment Therapy to Improve Social Support for Veterans with PTSD, ACT-SS, Present-Centered Therapy, PCT | VA Office of Research and Development | Post-traumatic Stress Disorder | 04/24 | 03/25 | | |
